{
    "medicine_id": "0a841742475bc4f19f826d0e3a90a72620a31247",
    "platform_id": "DB06217",
    "metadata": {
        "name": "Brinavess 20 MG ML Injection solution concentrate",
        "composition": "20 MG ML Vernakalant",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated for the rapid conversion of recent onset of atrial fibrillation to sinus rhythm in adults for non surgery patients that lasts for less than 7 days of duration and post cardiac surgery patients with atrial fibrillation lasting less than 3 days of duration",
            "contraindications": {
                "disease": "Some common unwanted effects include hypotension ventricular arrhythmias bradycardia atrial flutter dysgeusia paraesthesia dizziness and nausea",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Vernakalant blocks currents in all phases of atrial action potential including atria specific potassium currents the ultra rapid delayed rectifier and the acetylcholine dependent potassium currents and prolongs the refractory period It dose dependently prolongs atrial refractoriness prolongs AV nodal conduction and refractoriness and slightly prolongs QRS duration without significantly affecting ventricular refractory period Vernakalant has a high affinity to ion channels specifically involved in repolarization of atrial tissue and is thought to have a low proarrhythmic potential",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB08868",
                        "description": "Fingolimod may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The metabolism of Atomoxetine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Glimepiride may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Acetyldigitoxin may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Magnesium sulfate may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "Tocainide may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Deslanoside may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Dexpropranolol may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "Cyclandelate may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "Seletracetam may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Nylidrin may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00521",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Carteolol"
                    },
                    {
                        "drugbank-id": "DB01214",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Metipranolol"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tranilast"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Fasudil"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Agmatine"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Darodipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Niludipine"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Spiradoline"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Cymarin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13635",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tiracizine"
                    },
                    {
                        "drugbank-id": "DB13645",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Ethacizine"
                    },
                    {
                        "drugbank-id": "DB13718",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Hydroquinine"
                    },
                    {
                        "drugbank-id": "DB13746",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Bioallethrin"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Caroverine"
                    },
                    {
                        "drugbank-id": "DB13863",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Fosfructose"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "Vernakalant may increase the arrhythmogenic activities of WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Fish oil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB15300",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Hydroquinidine"
                    },
                    {
                        "drugbank-id": "DB15366",
                        "description": "Vernakalant may increase the arrhythmogenic activities of SOR C13"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Adenosine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Loperamide"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Azimilide"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Eperisone"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Benidipine"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Simendan"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Terodiline"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Pregabalin may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "Trimethadione may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Amlodipine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "Ethosuximide may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Verapamil may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Losartan may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "Levomenthol may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Felodipine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Nitrendipine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Bretylium may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Digitoxin may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "Methsuximide may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Cariporide"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Propafenone may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "Lidocaine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Esmolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Atenolol"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Alprenolol"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Nadolol"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Encainide"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Practolol"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Aprindine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Clevidipine"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Sparteine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Tertatolol"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Sotalol"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Procainamide"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Flecainide"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Lercanidipine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Clozapine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Primaquine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Lumefantrine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Imipramine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Lorcaserin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Vernakalant may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The metabolism of Quetiapine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The metabolism of Amphetamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Nicotine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Cevimeline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Bortezomib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Sildenafil can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The metabolism of Eletriptan can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The metabolism of Benzatropine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Bupivacaine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Acetaminophen can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Gefitinib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The metabolism of Codeine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The metabolism of Olanzapine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Chlorzoxazone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The metabolism of Mirtazapine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The metabolism of Palonosetron can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Progesterone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The metabolism of Remoxipride can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Zolpidem can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Prochlorperazine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Buspirone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The metabolism of Oxycodone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The metabolism of Dextromethorphan can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The metabolism of Lisuride can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Piperazine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Simvastatin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The metabolism of Galantamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Nicergoline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Amprenavir can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Tamsulosin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Nateglinide can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The metabolism of Risperidone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The metabolism of Meclizine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The metabolism of Minaprine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The metabolism of Donepezil can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Phenformin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Almotriptan can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Buprenorphine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The metabolism of Hydrocodone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The metabolism of Pindolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Azelastine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The metabolism of Formoterol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The metabolism of Methoxyflurane can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The metabolism of Tolterodine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Nefazodone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Dexfenfluramine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The metabolism of Oxymorphone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The metabolism of Lisdexamfetamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The metabolism of Arformoterol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The metabolism of Penbutolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The metabolism of Yohimbine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The metabolism of Tiotropium can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The metabolism of Midomafetamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The metabolism of Ethylmorphine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The metabolism of 4 Methoxyamphetamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The metabolism of Dihydrocodeine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The metabolism of Dextroamphetamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The metabolism of Metamfetamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The metabolism of Solifenacin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The metabolism of Lysergic acid diethylamide can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The metabolism of Lofexidine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The metabolism of Cariprazine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The metabolism of Sertindole can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The metabolism of Mianserin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Alogliptin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The metabolism of Esmirtazapine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The metabolism of Fesoterodine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Benzyl alcohol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Levomilnacipran can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Perospirone can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The metabolism of Umeclidinium can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The metabolism of Brexpiprazole can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The metabolism of Opium can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The metabolism of Rupatadine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The metabolism of Revefenacin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Triclabendazole can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Naloxegol"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Vernakalant can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Ciclesonide can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The metabolism of 5 methoxy N N dimethyltryptamine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Nabiximols"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The metabolism of Sertraline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Phenytoin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Doxepin"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Mephenytoin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The metabolism of Opipramol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The metabolism of Oliceridine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The metabolism of Epinastine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The metabolism of Encorafenib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Trospium"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Reboxetine"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Entacapone"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of Vernakalant can be decreased when combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Vernakalant can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Vernakalant can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Vernakalant can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Vernakalant can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Vernakalant can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Vernakalant can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Vernakalant can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Vernakalant can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Vernakalant can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Vernakalant can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Vernakalant can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Vernakalant can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Vernakalant can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Vernakalant can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Vernakalant can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Amitriptyline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The metabolism of Timolol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Vernakalant can be increased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The serum concentration of Escitalopram can be increased when it is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Vernakalant may increase the QTc prolonging activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Vernakalant can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Vernakalant can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of adverse effects can be increased when Vernakalant is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Vernakalant may increase the QTc prolonging activities of Pitolisant"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Vernakalant can be increased when it is combined with Fluoxetine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}